Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-Uptake Inhibitor (SSRI)
This study is currently recruiting participants.
Study NCT00249405 Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First Received: November 4, 2005 Last Updated: May 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcoholism
Alcohol Abuse
More general conditions related to this trial
Alcohol-Related Disorders
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Citalopram + MI
Placebo + MI
Additional drug interventions recognized in this trial
Citalopram
Dexetimide
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Back to top of Main Content
